UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 2.375

Sortiert nach

Bortezomib before and after high-dose therapy in myeloma: long-term results from the phase III HOVON-65/GMMG-HD4 trial

Leukemia, 2018-02, Vol.32 (2), p.383-390

2018

Volltextzugriff (PDF)

p53-dependent non-coding RNA networks in chronic lymphocytic leukemia

Leukemia, 2015-10, Vol.29 (10), p.2015-2023

2015

Volltextzugriff (PDF)

Phase III trial of bortezomib, cyclophosphamide and dexamethasone (VCD) versus bortezomib, doxorubicin and dexamethasone (PAd) in newly diagnosed myeloma

Leukemia, 2015-08, Vol.29 (8), p.1721-1729

2015

Volltextzugriff (PDF)

Predictive value of longitudinal whole-body magnetic resonance imaging in patients with smoldering multiple myeloma

Leukemia, 2014-09, Vol.28 (9), p.1902-1908

2014

Volltextzugriff (PDF)

Proliferation is a central independent prognostic factor and target for personalized and risk-adapted treatment in multiple myeloma

Haematologica (Roma), 2011-01, Vol.96 (1), p.87-95

2011

Volltextzugriff (PDF)

Concomitant gain of 1q21 and MYC translocation define a poor prognostic subgroup of hyperdiploid multiple myeloma

Haematologica (Roma), 2016-03, Vol.101 (3), p.e116

2016

Volltextzugriff (PDF)

Genomic profiling of Acute lymphoblastic leukemia in ataxia telangiectasia patients reveals tight link between ATM mutations and chromothripsis

Leukemia, 2017-10, Vol.31 (10), p.2048-2056

2017

Volltextzugriff (PDF)

Genome-wide association study of immunoglobulin light chain amyloidosis in three patient cohorts: comparison with myeloma

Leukemia, 2017-08, Vol.31 (8), p.1735-1742

2017

Volltextzugriff (PDF)

Genetics of neuroendocrine and carcinoid tumours

Endocrine-related cancer, 2003-12, Vol.10 (4), p.437-450

2003

Volltextzugriff (PDF)

Circulating tumor cells as a biomarker for response to therapy in multiple myeloma patients treated within the GMMG-MM5 trial

Bone marrow transplantation (Basingstoke), 2017-08, Vol.52 (8), p.1194-1198

2017

Volltextzugriff (PDF)

MLPA analysis for the detection of deletions, duplications and complex rearrangements in the dystrophin gene: potential and pitfalls

Neurogenetics, 2005-02, Vol.6 (1), p.29-35

2005

Volltextzugriff (PDF)

Bone morphogenic protein 6: a member of a novel class of prognostic factors expressed by normal and malignant plasma cells inhibiting proliferation and angiogenesis

Oncogene, 2009-11, Vol.28 (44), p.3866-3879

2009

Volltextzugriff (PDF)

S123: DECODING TRANSCRIPTOMIC AND EPIGENETIC CONSEQUENCES OF STRUCTURAL VARIANTS IN CK‐AML AT SINGLE‐CELL RESOLUTION

HemaSphere, 2022-06, Vol.6, p.24-25

2022

Volltextzugriff (PDF)

The telomere profile distinguishes two classes of genetically distinct cutaneous squamous cell carcinomas

Oncogene, 2014-07, Vol.33 (27), p.3506-3518

2014

Volltextzugriff (PDF)

Frequent loss of chromosome 9, homozygous CDKN2A/p14(ARF)/CDKN2B deletion and low TSC1 mRNA expression in pleomorphic xanthoastrocytomas

Oncogene, 2007-02, Vol.26 (7), p.1088-1097

2007

Volltextzugriff (PDF)

Trisomy 7 and 17 mark papillary renal cell tumours irrespectively of variation of the phenotype

Journal of clinical pathology, 2009-10, Vol.62 (10), p.892-895

2009

Volltextzugriff (PDF)

Frequent loss of chromosome 9, homozygous CDKN2A/p14ARF/CDKN2B deletion and low TSC1 mRNA expression in pleomorphic xanthoastrocytomas

Oncogene, 2007-02, Vol.26 (7), p.1088-1097

2007

Volltextzugriff (PDF)

Immunoglobulin light-chain amyloidosis shares genetic susceptibility with multiple myeloma

Leukemia, 2014-11, Vol.28 (11), p.2254-2256

2014

Volltextzugriff (PDF)

Silver-Russell syndrome due to maternal uniparental disomy 7 and a familial reciprocal translocation t(7;13)

Clinical genetics, 2012-11, Vol.82 (5), p.494-498

2012

Volltextzugriff (PDF)

Synergistic activity of imatinib and 17-AAG in imatinib-resistant CML cells overexpressing BCR-ABL - Inhibition of P-glycoprotein function by 17-AAG

Leukemia, 2005-07, Vol.19 (7), p.1198-1206

2005

Volltextzugriff (PDF)

Overexpression of the anti-apoptotic protein AVEN contributes to increased malignancy in hematopoietic neoplasms

Oncogene, 2013-05, Vol.32 (20), p.2586-2591

2013

Volltextzugriff (PDF)

Craniofrontonasal syndrome in a male due to chromosomal mosaicism involving EFNB1: further insights into a genetic paradox

Clinical genetics, 2014-04, Vol.85 (4), p.347-353

2014

Volltextzugriff (PDF)

Lack of CD56 expression on myeloma cells is not a marker for poor prognosis in patients treated by high-dose chemotherapy and is associated with translocation t(11;14)

Bone marrow transplantation (Basingstoke), 2007-12, Vol.40 (11), p.1033-1037

2007

Volltextzugriff (PDF)

Randomized Assessment of Rapid Endovascular Treatment of Ischemic Stroke

The New England journal of medicine, 2015-03, Vol.372 (11), p.1019-1030

2015

Volltextzugriff (PDF)

Association between magnetic resonance imaging patterns and baseline disease features in multiple myeloma: analyzing surrogates of tumor mass and biology

Clinical lymphoma, myeloma and leukemia, 2015-09, Vol.15, p.e98-e98

2015

Volltextzugriff (PDF)

1 – 25 von 2.375

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.972)
Mit Volltextzugriff
(2.020)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Stroke
(109)
Blood
(79)
Zentralblatt Für Chirurgie
(40)
Journal Of Clinical Oncology
(31)
Shock
(29)
Acta Crystallographica. Section A, Foundations Of Crystallography
(28)
Chirurg
(27)
Langenbeck's Archives Of Surgery
(25)
Transplantation Proceedings
(25)
Transplant International
(24)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(15)

Menü

Weitere Dienste

Einstellungen

Bortezomib before and after high-dose therapy in myeloma: long-term results from the phase III HOVON-65/GMMG-HD4 trial

p53-dependent non-coding RNA networks in chronic lymphocytic leukemia

Phase III trial of bortezomib, cyclophosphamide and dexamethasone (VCD) versus bortezomib, doxorubicin and dexamethasone (PAd) in newly diagnosed myeloma

Predictive value of longitudinal whole-body magnetic resonance imaging in patients with smoldering multiple myeloma

Proliferation is a central independent prognostic factor and target for personalized and risk-adapted treatment in multiple myeloma

Concomitant gain of 1q21 and MYC translocation define a poor prognostic subgroup of hyperdiploid multiple myeloma

Genomic profiling of Acute lymphoblastic leukemia in ataxia telangiectasia patients reveals tight link between ATM mutations and chromothripsis

Genome-wide association study of immunoglobulin light chain amyloidosis in three patient cohorts: comparison with myeloma

Genetics of neuroendocrine and carcinoid tumours

Circulating tumor cells as a biomarker for response to therapy in multiple myeloma patients treated within the GMMG-MM5 trial

MLPA analysis for the detection of deletions, duplications and complex rearrangements in the dystrophin gene: potential and pitfalls

Bone morphogenic protein 6: a member of a novel class of prognostic factors expressed by normal and malignant plasma cells inhibiting proliferation and angiogenesis

S123: DECODING TRANSCRIPTOMIC AND EPIGENETIC CONSEQUENCES OF STRUCTURAL VARIANTS IN CK‐AML AT SINGLE‐CELL RESOLUTION

The telomere profile distinguishes two classes of genetically distinct cutaneous squamous cell carcinomas

Frequent loss of chromosome 9, homozygous CDKN2A/p14(ARF)/CDKN2B deletion and low TSC1 mRNA expression in pleomorphic xanthoastrocytomas

Trisomy 7 and 17 mark papillary renal cell tumours irrespectively of variation of the phenotype

Frequent loss of chromosome 9, homozygous CDKN2A/p14ARF/CDKN2B deletion and low TSC1 mRNA expression in pleomorphic xanthoastrocytomas

Immunoglobulin light-chain amyloidosis shares genetic susceptibility with multiple myeloma

Silver-Russell syndrome due to maternal uniparental disomy 7 and a familial reciprocal translocation t(7;13)

Synergistic activity of imatinib and 17-AAG in imatinib-resistant CML cells overexpressing BCR-ABL - Inhibition of P-glycoprotein function by 17-AAG

Overexpression of the anti-apoptotic protein AVEN contributes to increased malignancy in hematopoietic neoplasms

Craniofrontonasal syndrome in a male due to chromosomal mosaicism involving EFNB1: further insights into a genetic paradox

Lack of CD56 expression on myeloma cells is not a marker for poor prognosis in patients treated by high-dose chemotherapy and is associated with translocation t(11;14)

Randomized Assessment of Rapid Endovascular Treatment of Ischemic Stroke

Association between magnetic resonance imaging patterns and baseline disease features in multiple myeloma: analyzing surrogates of tumor mass and biology

Suchergebnisse filtern